In a landscape where groundbreaking medical innovations often struggle to secure adequate financial backing, crowdfunding has emerged as a transformative force within the European Union's life sciences sector, redefining how capital-intensive projects like cancer drug development or medical device
In the ever-evolving landscape of healthcare investments, trust stands as the cornerstone of investor confidence, yet it can be shattered in an instant by allegations of corporate misconduct, as seen with Nutex Health. Once viewed as a promising player in the healthcare sector, the company now
What happens when the government, meant to be a neutral referee in the economic arena, steps onto the field as a player with a financial stake in one of the biggest tech giants? The recent decision by Washington to secure an 8.9 percent equity stake in Intel, a titan of the American semiconductor
Welcome to an insightful conversation on conduct risk, a critical topic for businesses navigating today’s complex regulatory landscape. I’m thrilled to be joined by Marco Gaietti, a veteran in management consulting with decades of experience in business management. Marco’s expertise in strategic
In a landscape where medical technology companies must constantly innovate to stay ahead, Medtronic (MDT) has emerged as a standout player with its sweeping governance overhaul and strategic realignment in the current year. This transformation, ignited by the influence of activist investor Elliott
China's digital economy, valued at a staggering $1.5 trillion, stands on the brink of a seismic shift as the updated Anti-Unfair Competition Law (AUCL) prepares to take effect on October 15 of this year. This isn't merely a minor adjustment but a sweeping regulatory overhaul designed to tackle the
